Triviraten is a vaccine used to prevent three serious viral diseases: measles, mumps, and rubella. It stimulates the immune system to produce antibodies that provide protection against these diseases, which can cause serious complications such as encephalitis, hearing loss, or pregnancy problems. This vaccine is usually given as part of routine childhood vaccination programs. It can also be given to unvaccinated adults to ensure their protection.
The Triviraten vaccine is administered by subcutaneous injection. Two doses are usually required to achieve full immunity. Some minor symptoms may occur after vaccination, such as redness or swelling at the injection site or a slight fever. These symptoms resolve spontaneously within a short period. It is important to adhere to the vaccination schedule recommended by health authorities to ensure effective and long-lasting protection.